Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on November 9, 2026

Nov. 9, 2026

Immuneering Appoints Accomplished Commercial Leader Grant Bogle to Board of Directors

Indeterminate GlobeNewswire

Nov. 9, 2026

BridgeBio to Participate in November and December Investor Conferences

Indeterminate GlobeNewswire

Nov. 9, 2026

Bicara Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 9, 2026

Cytokinetics Announces Additional Data Related to Aficamten Presented at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire

Nov. 9, 2026

CervoMed Reports Third Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

Nov. 9, 2026

Braveheart Bio to Participate in the Jefferies Global Healthcare Conference in London

Indeterminate GlobeNewswire

Nov. 9, 2026

Foghorn Therapeutics Provides Third Quarter 2026 Financial and Corporate Update

Indeterminate GlobeNewswire

Nov. 9, 2026

OrthoPediatrics Announces Full Commercial Launch of VerteGlide® Spinal Growth Guidance System

Indeterminate GlobeNewswire

Nov. 9, 2026

NeurAxis Reports Record Third Quarter 2026 Financial Results Driven by 150% Year Over Year Revenue Growth

Indeterminate GlobeNewswire

Nov. 9, 2026

Kamada Reports Record-High First Nine Months 2026 Financial Results; Increases 2026 Annual Guidance and Projects Double-Digit Growth in Revenues and Profitability in 2027

Indeterminate GlobeNewswire

Nov. 9, 2026

Myozyme Market Report Analyzes Market Trends, Segment Analysis, and Corporate Strategies

Indeterminate EIN Presswire

Nov. 9, 2026

Immunocore to present at upcoming investor conferences

Indeterminate GlobeNewswire

Nov. 9, 2026

Silexion Therapeutics Announces 1-for-24 Reverse Share Split

Indeterminate GlobeNewswire

Nov. 9, 2026

TRIDENT post-hoc analysis of low-dose triple combination therapy by kidney function in people with prior intracerebral hemorrhage presented at American Heart Association’s Scientific Sessions 2026

Indeterminate GlobeNewswire

Nov. 9, 2026

GT Biopharma Oral Presentation at the SITC 2026 Annual Meeting

Indeterminate GlobeNewswire

Nov. 9, 2026

NovaBridge Biosciences to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 9, 2026

Aura Biosciences Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Nov. 9, 2026

Aquestive Therapeutics to Present at the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

Nov. 9, 2026

Zenas BioPharma to Present at the Jefferies London Global Healthcare Conference

Indeterminate GlobeNewswire

Nov. 9, 2026

Adagene Announces Completion of Enrollment in Randomized Dose Optimization Phase 2 Trial of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer

Indeterminate GlobeNewswire